No sensory neuropathy during pyridoxine treatment in homocystinuria.
Chiedzo Mpofu, S M Alani, C. Whitehouse, Brian Fowler, J E Wraith
Abstract
Open-access reader
Chiedzo Mpofu, S M Alani, C. Whitehouse, Brian Fowler, J E Wraith
Abstract
Open-access reader
Seventeen patients with cystathionine synthase deficiency homocystinuria were examined clinically and neurophysiologically for evidence of sensory neuropathy. All had received high dose pyridoxine (vitamin B-6) for many years. Absence of neurological disturbance in all cases suggests long term treatment with pyridoxine in the dosages used in homocystinuric patients is not harmful.
OpenAlex reports 22 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Seventeen patients with cystathionine synthase deficiency homocystinuria were examined clinically and neurophysiologically for evidence of sensory neuropathy. All had received high dose pyridoxine (vitamin B-6) for many years. Absence of neurological disturbance in all cases suggests long term treatment with pyridoxine in the dosages used in homocystinuric patients is not harmful.
Key concepts: Homocystinuria, Pyridoxine, Medicine, Dose, Vitamin b6, Peripheral neuropathy, Cystathionine beta synthase, Sensory neuropathy